Online / Physical Event

8th Edition of International Conference on

Clinical and Medical Oncology

Theme: Building Bridges to Conquer Cancer

Event Date & Time

Event Location

London , UK

Program Abstract Registration Awards

18 years of lifescience communication

441518080160

Performers / Professionals From Around The Globe

Tracks & Key Topics

ONCOLOGY 2022

ABOUT CONFERENCE

We are glad to announce the 8th Edition of International Conference on Clinical and Medical Oncology (Oncology 2022) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members scheduled on March 24-25, 2022 in London, UK.

 Oncology 2022 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Oncology and Cancer. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Oncology 2022 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is “Building Bridges to Conquer Cancer”.

Oncology Conferences 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Who Should Attend??

Oncology 2022 conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Doctors, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Pediatric, Physicians, Advocacy, etc., to exchange about the state of the Research and Development.

Target Audience:

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetingsInteractive SessionsPanel DiscussionsKeynote SessionsPoster PresentationsOral PresentationsWorkshopsExhibitions etc., are the main highlights of this event.

Benefits of PHYSICAL EVENT:

Scope & Importance:

Oncology 2022 and Oncology Conference will seam world-class educators, scientists and Oncologists to converse diverse procedures for Cancer treatmentChemotherapy, and Radiology.

Oncology 2022 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

Overview of Oncology 2022:

The Innovative idea of Cancer has started great much research to be embraced by the labs around the world. With such an extraordinary number of researchers and scientists taking a shot at Caner research, to date, no significant solution for this is recorded. Oncology 2022 will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Oncology 2022 will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Cancer and in addition to check out the new thoughts and ideas on worldwide scale and the themes include Cancer And Its Relevance With Other Diseases, Advances In Cancer Research And Treatment, Cancer Causes And Risk Factors, Cancer Prevention Vaccines, Medical Imaging For Cancer, Cancer R&D Market Analysis, Cancer Screening & Diagnosis, Oncolytic Virus And Cancer, Cancer Nutrition And Metabolism, MicroRNA And Cancer, Managing Cancer Care & Patient Support, Radiology And Imaging Technologies, DNA Damage, Mutation And Cancer, Clinical And Medical Case Reports, Cancer Pathology And Genetics, Surgical And Clinical Oncology, Cancer Nanotechnology, Organ Specific Cancer, Cancer Epidemiology and SNP And Cancer.

 

SESSIONS & TRACKS

Track-1: Cancer Developmental Biology

Cell division could be a traditional method utilized by the body for growth and repair. Healthy cells stop dividing once there's not a requirement for additional female offspring cells; however cancer cells still turn out copies. Cancer cells square measure cells that divide unrelentingly, forming solid tumours or flooding the blood with abnormal cells. Cancer biology deals with these changes and also the molecular networks that management cell proliferation, differentiation and death. The study of varied styles of cancer is termed as medical specialty.

 

Track 1-1Cancer metabolomics

Track 1-2Regenerative cell biology

Track 1-3Host-pathogen interactions

Track 1-4Sarcoma

Track 1-5Renal Cell Carcinoma

Track-2: Clinical Oncology and Medical Case Reports

Clinical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumour, tumour site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

A case study is a research method involving an up-close, in-depth, and detailed examination of a concerned case (subject/topic), as well as its related contextual conditions. Case studies can be produced by a formal research method followed by an individual, organization, event, or action, existing in a specific time and place. Here we are inviting case studies based on any types of cancer or related incidents or events with facts and figures. Presenting your studies on any other type of cancer in this category will privilege you with a 30% discount on registration.

Track 2-1Cancer Physiology

Track 2-2Identifying Risk Factors

Track 2-3Cancer Biologic Factors

Track-3: Oncologic Emergencies in variety of subspecialties

The 3 major specialties of oncology are:

  • Medical oncology
  • Surgical oncology
  • Radiation oncology

There are several sub-specialties in the field of Oncology. The above mentioned specialties deal with the treatment of cancer through Chemotherapy or Immunotherapy, Biopsies and Radiology respectively.

Track 3-1Neuro-oncology

Track 3-2Ocular oncology

Track 3-3Head & Neck oncology

Track 3-4Thoracic oncology

Track 3-5Breast oncology

Track 3-6Gastrointestinal oncology

Track 3-7Bone & Musculoskeletal oncology

Track 3-8Dermatological oncology

Track 3-9Genitourinary oncology

Track 3-10Adolescent and young adult (AYA) oncology

Track 3-11Hemato oncology

Track 3-12Molecular oncology

Track 3-13Oncopathology

Track 3-14Nuclear medicine oncology

Track 3-15Veterinary oncology

Track 3-16Cardio Oncology

Track 3-17Computational Oncology

Track 3-18Exercises Oncology

Track-4: Nucleic acids damage, Mutation and Cancer

DNA is the repository of genetic information in each living cell, its integrity and stability is essential to life. DNA, however, is not inert; rather, it is a chemical entity subject to assault from the environment, and any resulting damage, if not repaired, will lead to mutation and possibly disease.

Track 4-1DNA damage and repair

Track 4-2RNA

Track 4-3Cancer genetics

Track 4-4Induced Mutagenesis in Cancer

Track 4-5Nuclear and Chromatin Dynamics

Track 4-6SNP- Cancer

Track 4-7Circulating Tumour DNA Analysis

Track-5: Cell signalling and regulation- Neurology

In biology, cell signaling is part of any communication process that governs basic activities of cells and coordinates multiple-cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing may cause diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, clinicians may treat diseases more effectively and, theoretically, researchers may develop artificial tissues.

All cells receive and respond to signals from their surroundings. This is accomplished by a variety of signal molecules that are secreted or expressed on the surface of one cell and bind to a receptor expressed by the other cells, thereby integrating and coordinating the function of the many individual cells that make up organisms. Each cell is programmed to respond to specific extracellular signal molecules. Extracellular signaling usually entails the following steps:

  • Synthesis and release of the signaling molecule by the signaling cell.
  • Transport of the signal to the target cell.
  • Binding of the signal by a specific receptor leading to its activation.
  • Initiation of signal-transduction pathways.

Track 5-1Genome integrity

Track 5-2Neurotransmitters

Track 5-3Signal transduction in cancer

Track 5-4Protein dynamics

Track 5-5Cancer: Redox signalling

Track-6: Cancer Immunology and Immunotherapy

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts.

Track 6-1Cancer Antigens & Vaccines

Track 6-2Host-Tumor Relation

Track 6-3Clinical Cancer immunology

Track 6-4Cellular Immunotherapy

Track 6-5Antibody Therapy

Track-7: Oncolytic Virus And Cancer

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses. The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccinia have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials.

Track 7-1Oncolytic behaviour of wild-type viruses

Track 7-2Bio-engineered oncolytic virus for the treatment of cancer

Track 7-3Recently approved therapeutic agents

Track-8: Bioscience- Oncology

Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment. Nanotechnology as defined by size is naturally very broad, including fields of science as diverse as surface science, organic chemistry, molecular biology, semiconductor physics, energy storage, microfabrication, molecular engineering, etc. The associated research and applications are equally diverse, ranging from extensions of conventional device physics to completely new approaches based upon molecular self-assembly, from developing new materials with dimensions on the nanoscale to direct control of matter on the atomic scale.